Chemoinformaics analysis of Methyl ent-3,E-13-clerodadien-15-oate
Molecular Weight | 318.501 | nRot | 4 |
Heavy Atom Molecular Weight | 284.229 | nRig | 13 |
Exact Molecular Weight | 318.256 | nRing | 2 |
Solubility: LogS | -5.461 | nHRing | 0 |
Solubility: LogP | 5.245 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 59.345 |
nHD | 0 | BPOL | 36.713 |
QED | 0.378 |
Synth | 4.17 |
Natural Product Likeliness | 3.02 |
NR-PPAR-gamma | 0.028 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.975 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.608 |
MDCK | 0.0000157 |
BBB | 0.285 |
PPB | 0.990198 |
VDSS | 3.253 |
FU | 0.0230197 |
CYP1A2-inh | 0.183 |
CYP1A2-sub | 0.718 |
CYP2c19-inh | 0.575 |
CYP2c19-sub | 0.957 |
CYP2c9-inh | 0.575 |
CYP2c9-sub | 0.522 |
CYP2d6-inh | 0.212 |
CYP2d6-sub | 0.605 |
CYP3a4-inh | 0.739 |
CYP3a4-sub | 0.462 |
CL | 7.863 |
T12 | 0.136 |
hERG | 0.016 |
Ames | 0.003 |
ROA | 0.022 |
SkinSen | 0.931 |
Carcinogencity | 0.038 |
EI | 0.376 |
Respiratory | 0.633 |
NR-Aromatase | 0.161 |
Antiviral | No |
Prediction | 0.58928 |